Conferences

IAC 2006, Toronto

The 16th International AIDS Conference (IAC) was held in Toronto in August 2006.
Transmission & prevention

Making prevention work: interventions with gay men

Transmission & prevention

Making prevention work: abstinence and partner reduction reviewed at World AIDS conference

Pregnancy, children & young people

HIV surveillance at immunisation clinics reveals weakness in KwaZulu Natal's PMTCT programme

Transmission & prevention

Awareness and use of HIV pre-exposure prophylaxis (PrEP) are found to be low in San Francisco gay and bisexual men

Hepatitis & HIV

Safer crack-smoking resources as a viable addition to comprehensive harm reduction programs for reducing HIV and HCV transmission

Improving HIV care

Many HIV-positive patients in London risking their health by use of alternative therapies

Treatment interruptions

SMART study - treatment breaks lower quality of life

Improving HIV care

Needle-free mode of T-20 dosing looks highly satisfactory for patients

Pregnancy, children & young people

Splitting Triomune tablets for children: smallest get poorest nevirapine dose

AZT/3TC before and after labour reduces HIV transmission whether infants fed with formula or breastfed and weaned early

Transmission & prevention

Gay men, methamphetamine and HIV: some issues explored at the Toronto conference

Transmission & prevention

Stress increases sexual risk-taking and risk of HIV for gay men

Ethnic & cultural minorities

Patients who need HIV therapy in London are accessing it, regardless of ethnicity or sexuality

Drug-resistant TB

Extensively drug-resistant TB rapidly fatal in South Africa

Transmission & prevention

Alphabet of prevention technologies expanding, but no 'magical solution'

Transmission & prevention

Sexually transmitted infections increase HIV risk for gay men

Epidemiology

India's HIV prevalence has been 'grossly overestimated'

Transmission & prevention

Is serosorting working, or even possible?

Hepatitis & HIV

HIV/HCV coinfected patients more prone to end-stage liver disease without treatment

Transmission & prevention

Over 40% of HIV-infected gay men in UK unaware of status; more than half believe they are HIV-negative

Transmission & prevention

Is Uganda's HIV prevention success story 'unravelling'?

Transmission & prevention

Pre-exposure prophylaxis ‘would be cost-effective’ if more than 50% efficacious

HIV treatment

Botswana’s adult HIV mortality rate falls since the rollout of free antiretroviral therapy

Transmission & prevention

The limits of PEP: saturation knowledge does not mean saturation use

Starting treatment

MK-0518 integrase inhibitor effective in treatment-naive patients

New & experimental HIV treatments

Maraviroc raises CD4 counts in patients with mixed-tropism virus, may offer value for highly treatment-experienced

HIV treatment

Access to treatment associated with declining stigma in Botswana

Starting treatment

Kaletra monotherapy as effective as triple therapy for at least 18 months

People with limited treatment options

Vicriviroc effective in treatment-experienced patients, but malignancy questions remain unanswered

New & experimental HIV treatments

TNX-355, new entry inhibitor, effective in highly treatment-experienced patients

Starting treatment

Efavirenz more durable than Kaletra over two years in treament-naive patients

Treatment interruptions

New data shed light on poor outcome in SMART study

People with limited treatment options

Merck launches expanded access programme for integrase inhibitor

Single-dose nevirapine not jeopardising mother's treatment, large Zambian study reports

How HIV works

Researchers launch hunt for people who control HIV without drugs

Starting treatment

Abacavir/3TC backbone proves most durable for children over five years

Improving HIV care

Anal cancer increases in French HIV cohort, despite use of antiretroviral therapy

TB diagnosis

Mixed results on ELISPOT TB testing in resource-limited settings

Pregnancy, children & young people

Oral solution of tipranavir/ritonavir shows promise for treatment-experienced kids

Pregnancy, children & young people

Ranbaxy presents bioequivalence data on two paediatric fixed dose triple combination tablets

Transmission & prevention

Circumcision could have beneficial effect regardless of change in condom use

Sexually transmitted infections epidemiology

High prevalence of cancerous and pre-cancerous cervical cell changes in HIV-positive women in Zambian study

Starting treatment

High rates of TB after beginning ART in Africa — but decreases observed over time

Sexually transmitted infections epidemiology

Sexually transmitted infections increase risk of HIV transmission in serodiscordant couples - but don't fully explain high infection rates

Chemsex & recreational drug use

US-led war on drugs 'inadvertently fuelling HIV epidemic'

Sexually transmitted infections prevention

Anti-herpes therapy reduces genital and plasma HIV viral load in women not taking HIV therapy

Side effects

Kaletra monotherapy - more encouraging results

Starting treatment

Two-class ART just as good as three-class in the long-term, and has fewer side-effects

Transmission & prevention

‘Opinion leader’ campaign in young black gay men achieves significant reductions in unsafe sex

TB transmission & prevention

Botswanan isoniazid preventative therapy trial screens out large numbers of people who are already ill

Transmission & prevention

First hint that PrEP might work in humans sparks debate on provision

New & experimental HIV treatments

Darunavir/ritonavir superior virologically and immunologically to comparator drugs over one year

People with limited treatment options

Selenium improves ART response in Nigerian randomised study

Sexually transmitted infections epidemiology

Sexual risk-taking may be associated with MRSA in HIV-positive individuals

Epidemiology

Randomised trial of food supplementation in food insecure patients ART inconclusive

Abbott cuts lopinavir price to $2200 for middle-income countries; new tablet marketed as Aluvia

Starting treatment

Very low CD4, rural care, linked to higher risk of death on ARVs in African studies

The search for an HIV prevention vaccine

`Put power to prevent HIV in the hands of women`, Bill and Melinda Gates tell AIDS Conference opening

Side effects

Brain problems and peripheral neuropathy under-diagnosed in Asia and the Pacific

Health services & systems

Abbott cuts lopinavir price to $2200 for middle-income countries; new tablet marketed as Aluvia